C3.ai Valuation
Is AI1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AI1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AI1 * (MX$441) is trading above our estimate of fair value (MX$133.42)
Significantly Below Fair Value: AI1 * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AI1 *?
Other financial metrics that can be useful for relative valuation.
What is AI1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$2.93b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.7x |
Enterprise Value/EBITDA | -7.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AI1 *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 19.4x | ||
300496 Thunder Software TechnologyLtd | 4.7x | 17.0% | CN¥24.1b |
RNG RingCentral | 1.2x | 7.2% | US$2.8b |
BL BlackLine | 5.4x | 9.3% | US$3.4b |
688318 Shenzhen Fortune Trend technology | 66.3x | 11.2% | CN¥28.8b |
AI1 * C3.ai | 9.4x | 18.5% | Mex$2.9b |
Price-To-Sales vs Peers: AI1 * is good value based on its Price-To-Sales Ratio (9.4x) compared to the peer average (19.4x).
Price to Earnings Ratio vs Industry
How does AI1 *'s PE Ratio compare vs other companies in the Global Software Industry?
Price-To-Sales vs Industry: AI1 * is expensive based on its Price-To-Sales Ratio (9.4x) compared to the Global Software industry average (3.1x).
Price to Sales Ratio vs Fair Ratio
What is AI1 *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 9.4x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AI1 *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$441.00 | Mex$507.89 +15.2% | 31.2% | Mex$799.70 | Mex$299.89 | n/a | 13 |
Sep ’25 | Mex$454.00 | Mex$512.82 +13.0% | 26.3% | Mex$708.74 | Mex$265.78 | n/a | 13 |
Aug ’25 | Mex$494.60 | Mex$512.82 +3.7% | 26.3% | Mex$708.74 | Mex$265.78 | n/a | 13 |
Jul ’25 | Mex$528.00 | Mex$512.82 -2.9% | 26.3% | Mex$708.74 | Mex$265.78 | n/a | 13 |
Jun ’25 | Mex$490.00 | Mex$497.66 +1.6% | 26.6% | Mex$678.63 | Mex$254.49 | n/a | 12 |
May ’25 | Mex$386.00 | Mex$489.33 +26.8% | 27.4% | Mex$668.38 | Mex$250.64 | n/a | 13 |
Apr ’25 | Mex$440.00 | Mex$489.33 +11.2% | 27.4% | Mex$668.38 | Mex$250.64 | n/a | 13 |
Mar ’25 | Mex$610.00 | Mex$492.12 -19.3% | 30.1% | Mex$680.74 | Mex$255.28 | n/a | 12 |
Feb ’25 | Mex$439.00 | Mex$458.34 +4.4% | 32.8% | Mex$687.51 | Mex$257.82 | n/a | 12 |
Jan ’25 | Mex$488.00 | Mex$456.04 -6.5% | 33.7% | Mex$688.36 | Mex$258.14 | n/a | 12 |
Dec ’24 | Mex$526.00 | Mex$468.44 -10.9% | 36.0% | Mex$722.00 | Mex$240.67 | n/a | 12 |
Nov ’24 | Mex$440.00 | Mex$458.98 +4.3% | 36.2% | Mex$738.84 | Mex$246.28 | n/a | 11 |
Oct ’24 | Mex$445.00 | Mex$458.98 +3.1% | 36.2% | Mex$738.84 | Mex$246.28 | Mex$479.00 | 11 |
Sep ’24 | Mex$528.00 | Mex$460.16 -12.8% | 42.1% | Mex$846.46 | Mex$237.01 | Mex$454.00 | 11 |
Aug ’24 | Mex$749.40 | Mex$460.16 -38.6% | 42.1% | Mex$846.46 | Mex$237.01 | Mex$494.60 | 11 |
Jul ’24 | Mex$636.00 | Mex$441.43 -30.6% | 42.8% | Mex$858.82 | Mex$240.47 | Mex$528.00 | 10 |
Jun ’24 | Mex$599.00 | Mex$451.12 -24.7% | 42.8% | Mex$877.67 | Mex$245.75 | Mex$490.00 | 10 |
May ’24 | Mex$355.72 | Mex$354.13 -0.4% | 30.9% | Mex$539.29 | Mex$215.71 | Mex$386.00 | 10 |
Apr ’24 | Mex$587.00 | Mex$375.08 -36.1% | 30.0% | Mex$553.39 | Mex$221.36 | Mex$440.00 | 9 |
Mar ’24 | Mex$375.00 | Mex$292.97 -21.9% | 36.0% | Mex$569.07 | Mex$208.66 | Mex$610.00 | 9 |
Feb ’24 | Mex$282.62 | Mex$267.48 -5.4% | 16.4% | Mex$372.99 | Mex$215.94 | Mex$439.00 | 8 |
Jan ’24 | Mex$215.00 | Mex$267.48 +24.4% | 16.4% | Mex$372.99 | Mex$215.94 | Mex$488.00 | 8 |
Dec ’23 | n/a | Mex$306.95 0% | 24.5% | Mex$499.10 | Mex$259.53 | Mex$526.00 | 8 |
Nov ’23 | n/a | Mex$306.95 0% | 24.5% | Mex$499.10 | Mex$259.53 | Mex$440.00 | 8 |
Oct ’23 | n/a | Mex$311.91 0% | 23.9% | Mex$499.06 | Mex$259.51 | Mex$445.00 | 8 |
Analyst Forecast: Target price is less than 20% higher than the current share price.